Working in partnership to deliver better Epilepsy services

31/01/13

Manchester

Matt Eddleston and Kate Trenam - Healthcare Partnership Managers

Agenda

A brief look at UCB

Objective of this session

The HPM Role and 2013 Objectives

Data tools for commissioning services

Data examples and case study

Working together – How and Who’s who?

Next steps

UCB: A patient-centric biopharma leader

3

2011 revenue: €3.2 billion

More than 8,000 employees globally

Operations in more than 40 countries

R&D Spend: 24% of revenue

Listed on Euronext

Stephanie, living with rheumatoid arthritis

Focusing on severe diseases inImmunology and the Central Nervous System

Mar 2012: UK/12MIS0027

UCB - Our Global Presence

4Mar 2012: UK/12MIS0027

5

UCB’s vision and strategies

Mar 2012: UK/12MIS0027

6

UCB in the UK

Carrie, living with Crohn’s diseaseMar 2012: UK/12MIS0027

UCB in the UK

Our UK site houses the immunology research hub and the head office for the UK commercial organisation

UK research hub focuses on research for conditions such as rheumatoid arthritis, epilepsy, lupus and osteoporosis

Employing approx 600 staff in the UK; 400 in R&D

Recently invested £25 million in the ‘UCB Biologics R&D Centre’; state-of-the-art laboratory

7Mar 2012: UK/12MIS0027

UCB in the UK

A top 5 investor in UK Pharmaceutical Research & Development (R&D): investing >£230 million in 2010*

Providing over 50 approved medicines within the UK

Supporting ~30 UK PhD's at any one time

Spending more than €500,000 annually on PhD support

8* Based upon data in the 2010 BIS R&D Scoreboard (BIS = Department for Business, Innovation & Skills Mar 2012: UK/12MIS0027

Summary

Against a backdrop of dramatic job cuts & reductions spend from many pharma companies; UCB has a more positive story to tell

We want to stay at the cutting edge; as a result we invest heavily in R&D• In 2011, R&D accounted for 24% of revenue• 40% of our research spend is in the UK and we continue to

invest in new facilities and research

Industry and academic and voluntary sector partnerships are essential for UCB

9Mar 2012: UK/12MIS0027

Objective

Provide clear understanding of HPM role

Provide a clear understanding of the data tools and how we use them

Provide a clear understanding of Commissioning Advocate Objectives

Identify opportunities for working together

Agree next steps

UCB Healthcare Partnership Managers

The NHS is changing The industry model is changing

Focus on the whole health economy not just on the benefits of the drugs we produce

• Government• National Commissioning• Local Commissioning• Trust Managers• Pharmacy• Clinicians

HPM

Creating Value in the NHS

VALUE

Reducing Costs

Improving Patient Experience

IncreasingEfficiency

HPM objectives 2013

Work in Partnership with the NHS to create value in Epilepsy

What is UCB’s offering?

Facilitate stakeholder meetingsProvide benchmarking dataShare best practice Help define the problems and solutionsAssist in commissioning through clear business plansImplement and promote the new services

The Commissioning Cycle

NEEDS ANALYSIS SERVICE DEVELOPMENTNEEDS ANALYSIS APPROVAL IMPLEMENATION

JSNANational PrioritiesTrust PrioritiesQIPPCQUINPatient Pathway

What are we changing?

Launch and PR

NHS Data Best practice

Facilitation

Business Case Development

Data Modelling

Launch meetingsPR DocumentationImpact review

Data tools

Hospital Episodes Statistics

NHS dataICD 10 Codes applied to all proceduresNHS find it difficult to manipulateQuantis database

South Yorkshire Epilepsy Project

Pathway Simulation Tool

NHS dataQOF or HESAssesses the impact of community services Simulat8

NE Lincs Neurology Project

South Yorkshire Epilepsy Project - Context

• Epilepsy services are not equitable across the region

• Sheffield does not have the capacity to continue with the same number of referrals to their tertiary clinics

• This in turn applies pressure on their general neurology clinics

• Doncaster and Rotherham per population do not have equitable services to those in Sheffield and Barnsley

STAKEHOLDERSClinical lead engaged and motivated

CCG Commissioner engaged and motivated

GP’s engaged

Project Objective

Deliver equitable and sustainable Epilepsy services in Sheffield, Barnsley, Doncaster and Rotherham

• Improve services in Doncaster and Rotherham to relieve pressure on Sheffield

Return for the patient and the NHS

NHS

Reduction in referral costs – tertiary and general neurologyReinvestment into community servicesReduction in variationGood model of partnership working in new NHS

Patient

Reduction in variationRight treatment right timeCare closer to homeBetter all round management = better QOL

Return for UCB?

HES data

Epilepsy pathway simulation tool

The Pathway tool ‘Simul8’ uses either HES or QOF data to map the patient pathway from diagnosis through to secondary careIt then looks at the impact of introducing community services in the form of specialist nurses and dedicated telephone servicesThe results form the basis of a written report that we will pull together looking at, amongst other things, patient through put and of course costThe next slide is a screen shot of the tool

Epilepsy pathway simulation tool

Epilepsy pathway simulation tool

Typical report

Epilepsy Action and UCB working in partnership to deliver better services - Opportunities

An alliance to reduce inequalities in epilepsy healthcareThe NHS are looking for complete solutions

HPM team and Commissioning Advocates:• Same objectives• Compliment each others work• Data provision and funding• Best practice and expertise• Driving Epilepsy on the agenda• Referrals • Local meetings

Who’s Who?

1) Manchester2) Stockport

Harrogate

Sheffield

Scarborough

Chester le Street

London

Coventry

West Midlands

Dorking

Contact Details

matt.eddleston@ucb.com - 07770 960 168• Lancashire, Merseyside, Greater Manchester, Yorkshire, Lincolnshire

Kate.trenham@ucb.com - 07976 600 594• Sussex, Surrey, Hampshire, IOW, Gloucestershire, Somerset, Devon, Cornwall,

Dorset

vincenzo.straccia@ucb.com - 07841 959 039• Norfolk, Suffolk, Greater London, Essex, Kent, Bedfordshire, Cambridgeshire,

Northamptonshire

suzanne.fletcher@ucb.com - 07713 074 083• Oxfordshire, Thames Valley, Staffordshire, E&W Midlands, Leicester, Derbyshire,

Nottinghamshire

david.walter@ucb.com – 07768 107 597• National Healthcare Partnership Manager

• Flip chart Advocate details• ADD GUY A

Next Steps

HPM to contact equivalent commissioning advocate

Agree local meeting

Discuss local objectives

Agree plan for working together• Are there existing projects where we could work

together?• Where could we target together?

Questions?